辅助溶栓增强血栓切除成功后的脑再灌注
这项单中心随机双盲安慰剂对照研究纳入36例大血管闭塞并接受血栓切除术、血管造影再灌注接近正常或正常的患者,比较动脉内阿替普酶(0.225mg/kg)与安慰剂的疗效。结果显示阿替普酶组48小时MRI低灌注比例低于安慰剂组(24% vs 58%,校正OR=0.20,95%CI 0.04-0.91,p=0.03),梗死体积扩大比更低,NAA峰值更高。
要点
- 血栓切除成功后造影再灌注正常者仍有较高比例存在MRI低灌注区。
- 动脉内阿替普酶辅助治疗可降低48小时MRI低灌注比例(24% vs 58%)。
- 阿替普酶组梗死体积扩大比较低、NAA峰值较高,提示神经元完整性改善。
核心结论
- 血栓切除术后尽管血管造影显示再灌注成功,MRI低灌注区仍常见;辅助阿替普酶可增强脑再灌注,从而减少梗死扩大并改善神经元完整性。
研究设计与样本
- 单中心、随机、双盲、安慰剂对照研究,纳入36例大血管闭塞接受血栓切除术且血管造影再灌注接近正常或正常的患者(平均年龄70.8岁,标准差13.5,女性18例占50%)。
- 17例随机接受动脉内阿替普酶0.225mg/kg,19例接受安慰剂。
- 主要结局为48小时MRI低灌注区患者比例的差异;次要结局为梗死扩大比和NAA峰值相对总肌酸。
主要发现
- 48小时MRI低灌注比例:阿替普酶组24% vs 安慰剂组58%(校正OR=0.20,95%CI 0.04-0.91,p=0.03)。
- 最终eTICI 3分的14例患者中,低灌注见于阿替普酶组7例中的1例(14%)和安慰剂组7例中的3例(43%)。
- 梗死扩大比:阿替普酶组中位数0.7(IQR 0.5-1.2)vs 安慰剂组3.2(IQR 1.8-5.7),p=0.01。
- NAA峰值:阿替普酶组中位数1.13(IQR 0.91-1.36)vs 安慰剂组1.00(IQR 0.74-1.22),p<0.0001。
- 异常脑灌注与第90天较差功能结局相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was undertaken to investigate whether adjunct alteplase improves brain reperfusion following successful thrombectomy. METHODS: This single-center, randomized, double-blind, placebo-controlled study included 36 patients (mean [standard deviation] = 70.8 [13.5] years old, 18 [50%] women) with large vessel occlusion undergoing thrombectomy resulting in near-normal (expanded Thrombolysis in Cerebral Infarction [eTICI] b50/67/2c, n = 23, 64%) or normal angiographic reperfusion (eTICI 3, n = 13, 36%). Seventeen patients were randomized to intra-arterial alteplase (0.225mg/kg), and 19 received placebo. At 48 hours, patients had brain perfusion/diffusion-weighted magnetic resonance imaging (MRI) and MRI-spectroscopy. The primary outcome was the difference in the proportion of patients with areas of hypoperfusion on MRI. Secondary outcomes were the infarct expansion ratio (final to initial infarction volume), and the N-acetylaspartate (NAA) peak relative to total creatine as a marker of neuronal integrity. RESULTS: The prevalence of hypoperfusion was 24% with intra-arterial alteplase, and 58% with placebo (adjusted odds ratio = 0.20, 95% confidence interval [CI] = 0.04-0.91, p = 0.03). Among 14 patients with final eTICI 3 scores, hypoperfusion was found in 1 of 7 (14%) in the alteplase group and 3 of 7 (43%) in the placebo group. Abnormal brain perfusion was associated with worse functional outcome at day 90. Alteplase significantly reduced the infarct expansion ratio compared with placebo (median [interquartile range (IQR)] = 0.7 [0.5-1.2] vs 3.2 [1.8-5.7], p = 0.01) and resulted in higher NAA peaks (median [IQR] = 1.13 [0.91-1.36] vs 1.00 [0.74-1.22], p < 0.0001). INTERPRETATION: There is a high prevalence of areas of hypoperfusion following thrombectomy despite successful reperfusion on angiography. Adjunct alteplase enhances brain reperfusion, which results in reduced expansion of the infarction and improved neuronal integrity. ANN NEUROL 2022;92:860-870.
引用
- Laredo C, Rodríguez A, Oleaga L, et al. Adjunct Thrombolysis Enhances Brain Reperfusion following Successful Thrombectomy. Ann Neurol. 2022. PMID: 36054449. doi:10.1002/ana.26474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。